RNA Biomarker

© Fraunhofer IZI

The unit is primarily concerned with searching for and validating new diagnostic and prognostic RNA biomarkers for a number of different diseases. It has a range of molecular methods available for the screening and validation process in line with GLP, e.g. next generation sequencing, microarrays, and PCR-based methods. An additional focus lies on accompanying diagnostics, which is viewed as a key step towards personalized healthcare. The team develops specific tests (e.g. for diagnosing cancer) to help them reach this ideal goal.


Here is an overview of the methods we use.


Here we show you a selection of current projects.


Find out here about the devices and systems that we use for our work.


Here you will find an overview of all publications that have emerged from the research work of our unit.